Marc Bonaca, MD
PeerNo benefit of routine spironolactone post-MI
Sanjit Jolly, MD
PeerSubodh Verma, MD, PhD
PeerStephen Nicholls, FRACP, FACC, FESC, FAHA
PeerStephen Nicholls, FRACP, FACC, FESC, FAHA
PeerJasvinder Singh, MD
PeerJasvinder Singh, MD
PeerShawna Nesbitt, MD
PeerMilton Packer, MD
PeerChisato Izumi, MD, PhD
PeerLéna Rivard, MD
PeerAcoramidis reduces all-cause mortality in ATTR-CM
Daniel Judge, MD
PeerAlexander Sandhu, MD
PeerKausik Ray, MBChB, MD, MPhil
PeerAssessing the AMA MAP™ Hypertension Program’s Impact at Rush University Medical Center